Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 895

1.

Tractography reproducibility challenge with empirical data (TraCED): The 2017 ISMRM diffusion study group challenge.

Nath V, Schilling KG, Parvathaneni P, Huo Y, Blaber JA, Hainline AE, Barakovic M, Romascano D, Rafael-Patino J, Frigo M, Girard G, Thiran JP, Daducci A, Rowe M, Rodrigues P, Prčkovska V, Aydogan DB, Sun W, Shi Y, Parker WA, Ould Ismail AA, Verma R, Cabeen RP, Toga AW, Newton AT, Wasserthal J, Neher P, Maier-Hein K, Savini G, Palesi F, Kaden E, Wu Y, He J, Feng Y, Paquette M, Rheault F, Sidhu J, Lebel C, Leemans A, Descoteaux M, Dyrby TB, Kang H, Landman BA.

J Magn Reson Imaging. 2019 Jun 9. doi: 10.1002/jmri.26794. [Epub ahead of print]

PMID:
31179595
2.

Characterization of lenticulostriate arteries with high resolution black-blood T1-weighted turbo spin echo with variable flip angles at 3 and 7 Tesla.

Ma SJ, Sarabi MS, Yan L, Shao X, Chen Y, Yang Q, Jann K, Toga AW, Shi Y, Wang DJJ.

Neuroimage. 2019 May 31;199:184-193. doi: 10.1016/j.neuroimage.2019.05.065. [Epub ahead of print]

PMID:
31158475
3.

Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.

Zhao Q, Liu M, Ha L, Zhou Y; Alzheimer's Disease Neuroimaging Initiative.

Front Neurol. 2019 May 15;10:486. doi: 10.3389/fneur.2019.00486. eCollection 2019.

4.

Imputation Strategy for Reliable Regional MRI Morphological Measurements.

Sta Cruz S, Dinov ID, Herting MM, González-Zacarías C, Kim H, Toga AW, Sepehrband F.

Neuroinformatics. 2019 May 4. doi: 10.1007/s12021-019-09426-x. [Epub ahead of print]

PMID:
31054076
5.

Perivascular space fluid contributes to diffusion tensor imaging changes in white matter.

Sepehrband F, Cabeen RP, Choupan J, Barisano G, Law M, Toga AW; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2019 Aug 15;197:243-254. doi: 10.1016/j.neuroimage.2019.04.070. Epub 2019 Apr 30.

PMID:
31051291
6.

Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer's disease.

Sepehrband F, Cabeen RP, Barisano G, Sheikh-Bahaei N, Choupan J, Law M, Toga AW.

Alzheimers Dement (Amst). 2019 Apr 22;11:348-354. doi: 10.1016/j.dadm.2019.03.002. eCollection 2019 Dec.

7.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.

Franzmeier N, Rubinski A, Neitzel J, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2019 Apr 16;10(1):1766. doi: 10.1038/s41467-019-09564-5.

8.

Predictive Big Data Analytics using the UK Biobank Data.

Zhou Y, Zhao L, Zhou N, Zhao Y, Marino S, Wang T, Sun H, Toga AW, Dinov ID.

Sci Rep. 2019 Apr 12;9(1):6012. doi: 10.1038/s41598-019-41634-y.

9.

A blood-based signature of cerebrospinal fluid Aβ1-42 status.

Goudey B, Fung BJ, Schieber C, Faux NG; Alzheimer’s Disease Metabolomics Consortium; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Mar 11;9(1):4163. doi: 10.1038/s41598-018-37149-7.

10.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.

Varatharajah Y, Ramanan VK, Iyer R, Vemuri P; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 19;9(1):2235. doi: 10.1038/s41598-019-38793-3.

11.

Predicting Alzheimer's disease progression using multi-modal deep learning approach.

Lee G, Nho K, Kang B, Sohn KA, Kim D; for Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 13;9(1):1952. doi: 10.1038/s41598-018-37769-z.

12.

Type 2 diabetes mellitus, brain atrophy, and cognitive decline.

Moran C, Beare R, Wang W, Callisaya M, Srikanth V; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurology. 2019 Feb 19;92(8):e823-e830. doi: 10.1212/WNL.0000000000006955. Epub 2019 Jan 23.

PMID:
30674592
13.

Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.

Nation DA, Sweeney MD, Montagne A, Sagare AP, D'Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Chui HC, Law M, Toga AW, Zlokovic BV.

Nat Med. 2019 Feb;25(2):270-276. doi: 10.1038/s41591-018-0297-y. Epub 2019 Jan 14.

14.

Vascular dysfunction-The disregarded partner of Alzheimer's disease.

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Salman RA, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, González HM, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O'Brien JT, Skoog I, Pantoni L, Gustafson DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV.

Alzheimers Dement. 2019 Jan;15(1):158-167. doi: 10.1016/j.jalz.2018.07.222.

15.

Harmonization of pipeline for preclinical multicenter MRI biomarker discovery in a rat model of post-traumatic epileptogenesis.

Immonen R, Smith G, Brady RD, Wright D, Johnston L, Harris NG, Manninen E, Salo R, Branch C, Duncan D, Cabeen R, Ndode-Ekane XE, Gomez CS, Casillas-Espinosa PM, Ali I, Shultz SR, Andrade P, Puhakka N, Staba RJ, O'Brien TJ, Toga AW, Pitkänen A, Gröhn O.

Epilepsy Res. 2019 Feb;150:46-57. doi: 10.1016/j.eplepsyres.2019.01.001. Epub 2019 Jan 7.

PMID:
30641351
16.

Analytic Tools for Post-traumatic Epileptogenesis Biomarker Search in Multimodal Dataset of an Animal Model and Human Patients.

Duncan D, Barisano G, Cabeen R, Sepehrband F, Garner R, Braimah A, Vespa P, Pitkänen A, Law M, Toga AW.

Front Neuroinform. 2018 Dec 20;12:86. doi: 10.3389/fninf.2018.00086. eCollection 2018.

17.

The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T; Parkinson's Progression Markers Initiative.

Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477. doi: 10.1002/acn3.644. eCollection 2018 Dec.

18.

Age-Related Differences in Brain Morphology and the Modifiers in Middle-Aged and Older Adults.

Zhao L, Matloff W, Ning K, Kim H, Dinov ID, Toga AW.

Cereb Cortex. 2018 Dec 7. doi: 10.1093/cercor/bhy300. [Epub ahead of print]

PMID:
30535294
19.

7-Tesla MRI of the brain in a research subject with bilateral, total knee replacement implants: Case report and proposed safety guidelines.

Barisano G, Culo B, Shellock FG, Sepehrband F, Martin K, Stevens M, Wang DJ, Toga AW, Law M.

Magn Reson Imaging. 2019 Apr;57:313-316. doi: 10.1016/j.mri.2018.11.016. Epub 2018 Nov 27.

PMID:
30496792
20.

Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.

Lyden P, Pryor KE, Coffey CS, Cudkowicz M, Conwit R, Jadhav A, Sawyer RN Jr, Claassen J, Adeoye O, Song S, Hannon P, Rost NS, Hinduja A, Torbey M, Lee JM, Benesch C, Rippee M, Rymer M, Froehler MT, Clarke Haley E, Johnson M, Yankey J, Magee K, Qidwai J, Levy H, Mark Haacke E, Fawaz M, Davis TP, Toga AW, Griffin JH, Zlokovic BV; NeuroNEXT Clinical Trials Network NN104 Investigators.

Ann Neurol. 2019 Jan;85(1):125-136. doi: 10.1002/ana.25383. Epub 2019 Jan 7.

PMID:
30450637
21.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2019 Jul;56(7):4916-4924. doi: 10.1007/s12035-018-1405-1. Epub 2018 Nov 9.

PMID:
30414086
22.

DETECTING FEATURES OF EPILEPTOGENESIS IN EEG AFTER TBI USING UNSUPERVISED DIFFUSION COMPONENT ANALYSIS.

Duncan D, Vespa P, Toga AW.

Discrete Continuous Dyn Syst Ser B. 2018 Jan;23(1):161-172. doi: 10.3934/dcdsb.2018010.

23.

Clinical 7 T MRI: Are we there yet? A review about magnetic resonance imaging at ultra-high field.

Barisano G, Sepehrband F, Ma S, Jann K, Cabeen R, Wang DJ, Toga AW, Law M.

Br J Radiol. 2019 Feb;92(1094):20180492. doi: 10.1259/bjr.20180492. Epub 2018 Nov 1. Review.

PMID:
30359093
24.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.

Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Warren JD, Crutch S, Fox NC, Ourselin S, Schott JM, Rohrer JD, Alexander DC; Genetic FTD Initiative (GENFI); Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0.

25.

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.

Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Jan;15(1):106-152. doi: 10.1016/j.jalz.2018.08.005. Epub 2018 Oct 13. Review.

PMID:
30321505
26.

Limits to anatomical accuracy of diffusion tractography using modern approaches.

Schilling KG, Nath V, Hansen C, Parvathaneni P, Blaber J, Gao Y, Neher P, Aydogan DB, Shi Y, Ocampo-Pineda M, Schiavi S, Daducci A, Girard G, Barakovic M, Rafael-Patino J, Romascano D, Rensonnet G, Pizzolato M, Bates A, Fischi E, Thiran JP, Canales-Rodríguez EJ, Huang C, Zhu H, Zhong L, Cabeen R, Toga AW, Rheault F, Theaud G, Houde JC, Sidhu J, Chamberland M, Westin CF, Dyrby TB, Verma R, Rathi Y, Irfanoglu MO, Thomas C, Pierpaoli C, Descoteaux M, Anderson AW, Landman BA.

Neuroimage. 2019 Jan 15;185:1-11. doi: 10.1016/j.neuroimage.2018.10.029. Epub 2018 Oct 11.

27.

Hippocampal Shape Maturation in Childhood and Adolescence.

Lynch KM, Shi Y, Toga AW, Clark KA; Pediatric Imaging, Neurocognition and Genetics Study.

Cereb Cortex. 2018 Oct 1. doi: 10.1093/cercor/bhy244. [Epub ahead of print]

PMID:
30272143
28.

The role of brain vasculature in neurodegenerative disorders.

Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV.

Nat Neurosci. 2018 Oct;21(10):1318-1331. doi: 10.1038/s41593-018-0234-x. Epub 2018 Sep 24. Review.

29.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease.

Huang SY, Hsu JL, Lin KJ, Liu HL, Wey SP, Hsiao IT; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2018 Sep 14;8(1):13807. doi: 10.1038/s41598-018-31794-8.

30.

Testing a Multivariate Proteomic Panel for Traumatic Brain Injury Biomarker Discovery: A TRACK-TBI Pilot Study.

Huie JR, Diaz-Arrastia R, Yue JK, Sorani MD, Puccio AM, Okonkwo DO, Manley GT, Ferguson AR; TRACK-TBI Investigators.

J Neurotrauma. 2019 Jan 1;36(1):100-110. doi: 10.1089/neu.2017.5449. Epub 2018 Sep 27.

PMID:
30084741
31.

Modeling topographic regularity in structural brain connectivity with application to tractogram filtering.

Wang J, Aydogan DB, Varma R, Toga AW, Shi Y.

Neuroimage. 2018 Dec;183:87-98. doi: 10.1016/j.neuroimage.2018.07.068. Epub 2018 Aug 4.

PMID:
30081193
32.

Using Virtual Reality to Improve Performance and User Experience in Manual Correction of MRI Segmentation Errors by Non-experts.

Duncan D, Garner R, Zrantchev I, Ard T, Newman B, Saslow A, Wanserski E, Toga AW.

J Digit Imaging. 2019 Feb;32(1):97-104. doi: 10.1007/s10278-018-0108-5.

PMID:
30030766
33.

Big data sharing and analysis to advance research in post-traumatic epilepsy.

Duncan D, Vespa P, Pitkänen A, Braimah A, Lapinlampi N, Toga AW.

Neurobiol Dis. 2019 Mar;123:127-136. doi: 10.1016/j.nbd.2018.05.026. Epub 2018 Jun 1. Review.

PMID:
29864492
34.

Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework.

Ning K, Chen B, Sun F, Hobel Z, Zhao L, Matloff W; Alzheimer's Disease Neuroimaging Initiative, Toga AW.

Neurobiol Aging. 2018 Aug;68:151-158. doi: 10.1016/j.neurobiolaging.2018.04.009. Epub 2018 Apr 24.

PMID:
29784544
35.

When tractography meets tracer injections: a systematic study of trends and variation sources of diffusion-based connectivity.

Aydogan DB, Jacobs R, Dulawa S, Thompson SL, Francois MC, Toga AW, Dong H, Knowles JA, Shi Y.

Brain Struct Funct. 2018 Jul;223(6):2841-2858. doi: 10.1007/s00429-018-1663-8. Epub 2018 Apr 16.

36.

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.

Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K; Parkinson's Progression Marker Initiative*.

Mov Disord. 2018 May;33(5):771-782. doi: 10.1002/mds.27361. Epub 2018 Mar 23.

37.

Value of pituitary gland MRI at 7 T in Cushing's disease and relationship to inferior petrosal sinus sampling: case report.

Law M, Wang R, Liu CJ, Shiroishi MS, Carmichael JD, Mack WJ, Weiss M, Wang DJJ, Toga AW, Zada G.

J Neurosurg. 2018 Mar 1:1-5. doi: 10.3171/2017.9.JNS171969. [Epub ahead of print]

PMID:
29570013
38.

Classification of MRI and psychological testing data based on support vector machine.

Yang W, Chen X, Cohen DS, Rosin ER, Toga AW, Thompson PM, Huang X.

Int J Clin Exp Med. 2017 Dec;10(12):16004-16026.

39.

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia.

Therriault J, Ng KP, Pascoal TA, Mathotaarachchi S, Kang MS, Struyfs H, Shin M, Benedet AL, Walpola IC, Nair V, Gauthier S, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2018 Mar 13;90(11):e932-e939. doi: 10.1212/WNL.0000000000005120. Epub 2018 Feb 14.

40.

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis.

Zhou X, Chen Y, Mok KY, Zhao Q, Chen K, Chen Y, Hardy J, Li Y, Fu AKY, Guo Q, Ip NY; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1697-1706. doi: 10.1073/pnas.1715554115. Epub 2018 Feb 5.

41.

Neuroanatomical morphometric characterization of sex differences in youth using statistical learning.

Sepehrband F, Lynch KM, Cabeen RP, Gonzalez-Zacarias C, Zhao L, D'Arcy M, Kesselman C, Herting MM, Dinov ID, Toga AW, Clark KA.

Neuroimage. 2018 May 15;172:217-227. doi: 10.1016/j.neuroimage.2018.01.065. Epub 2018 Feb 3.

42.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP; Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study Group; Neurologic Outcomes Research Group (NORG).

Anesthesiology. 2018 Apr;128(4):728-744. doi: 10.1097/ALN.0000000000002103.

43.

Statistical tests and identifiability conditions for pooling and analyzing multisite datasets.

Zhou HH, Singh V, Johnson SC, Wahba G; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1481-1486. doi: 10.1073/pnas.1719747115. Epub 2018 Jan 31.

44.

A probabilistic atlas of human brainstem pathways based on connectome imaging data.

Tang Y, Sun W, Toga AW, Ringman JM, Shi Y.

Neuroimage. 2018 Apr 1;169:227-239. doi: 10.1016/j.neuroimage.2017.12.042. Epub 2017 Dec 16.

45.

Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty.

Du L, Liu K, Yao X, Yan J, Risacher SL, Han J, Guo L, Saykin AJ, Shen L; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2017 Oct 25;7(1):14052. doi: 10.1038/s41598-017-13930-y.

46.

Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.

Risacher SL, Anderson WH, Charil A, Castelluccio PF, Shcherbinin S, Saykin AJ, Schwarz AJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Nov 21;89(21):2176-2186. doi: 10.1212/WNL.0000000000004670. Epub 2017 Oct 25.

47.

In vivo staging of regional amyloid deposition.

Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2017 Nov 14;89(20):2031-2038. doi: 10.1212/WNL.0000000000004643. Epub 2017 Oct 18.

48.

Topographic Regularity for Tract Filtering in Brain Connectivity.

Wang J, Aydogan DB, Varma R, Toga AW, Shi Y.

Inf Process Med Imaging. 2017 Jun;10265:263-274. doi: 10.1007/978-3-319-59050-9_21. Epub 2017 May 23.

49.

Corrigendum: Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.

Guo S, Lai C, Wu C, Cen G; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 Sep 5;9:293. doi: 10.3389/fnagi.2017.00293. eCollection 2017.

50.

Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang LS, Romero K, Arneric SP, Redolfi A, Orlandi D, Frisoni GB, Au R, Devine S, Auerbach S, Espinosa A, Boada M, Ruiz A, Johnson SC, Koscik R, Wang JJ, Hsu WC, Chen YL, Toga AW.

JAMA Neurol. 2017 Oct 1;74(10):1178-1189. doi: 10.1001/jamaneurol.2017.2188.

Supplemental Content

Loading ...
Support Center